Merge collaborates with Methodist Healthcare

Article

Methodist Healthcare of Memphis has joined the Merge Premier Partner Program. Through this program, Merge collaborates with leading clinical partners to develop medical communication and informatics solutions for diagnostic imaging that lower healthcare

Methodist Healthcare of Memphis has joined the Merge Premier Partner Program. Through this program, Merge collaborates with leading clinical partners to develop medical communication and informatics solutions for diagnostic imaging that lower healthcare operating costs, increase efficiencies, reduce medical errors, and improve patient care. As a partner, Methodist Healthcare will receive a license to Merge’s medical software tools, such as MergeWeb for clinical workflow research and product development. Merge will receive ongoing clinical input, commercial rights for products codeveloped with its partners, and a network of clinical trial and reference sites. Several of Merge’s Premier Partners are its customers. Other partners include Medical College of Wisconsin, UCLA Medical Center, and Mallinckrodt Institute of Radiology.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.